Drug Type Small molecule drug |
Synonyms CDE-001 |
Target |
Action inhibitors, agonists |
Mechanism NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), PPAR agonists(Peroxisome proliferator activated receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dermatitis | Preclinical | Spain | - | |
Abdominal Obesity Metabolic Syndrome | Discovery | Spain | - |